|
|
 |
|
Viewing report
|
|
|
|
Global Diabetes Market
Frost & Sullivan, June 2009, Pages: 99
This Frost & Sullivan research service titled Global Diabetes Market provides insight into key industry challenges, market drivers and trends. Defining trends are examined along with revenue forecasts. A SWOT analysis is provided of the diabetes markets in the United States, Europe, Japan and rest of the world. In this research, Frost & Sullivan's expert analysts thoroughly examine the following diabetes markets: the US, Europe, Japan and the Rest-of-World. Insulin and insulin analogues and non-insulin anti-diabetic drugs markets are also studied in the research.
This analysis is available through our Pharmaceuticals & Biotechnology Growth Partnership Service programme. With continuous access to intelligence and resources from all seven perspectives of the Complex Business Universe, the Growth Partnership Services programme ensures that you and your Growth Team™ are able to maintain a 360 Degree Perspective of the market. This comprehensive, objective information allows your company to mitigate risk, identify new opportunities and drive effective strategies for growth. For more information on this custom subscription service, please click here.
Market Overview
Emergence of Novel Drug Classes to Boost Market Growth
Increasing knowledge related to the pathology of diabetes will support the introduction of improved drugs to treat the disease. As healthcare moves towards the ideal of preventive medicine, there are a few companies conducting research on diabetes vaccines. If they succeed, the entire market landscape is bound to undergo instant change.
“Improved therapies and innovative drug delivery techniques are anticipated to revolutionise the global diabetes market by 2015,” notes the analyst of this research. “As healthcare moves towards preventive medicine, the search for a cure for diabetes looks promising.” The emergence of newer classes of drugs to treat diabetes and their co-morbidities is changing the diabetes market landscape. Long-acting GLP-1 analogs are likely to gain significance and almost match the importance of insulin in the near future. This trend is likely to be beneficial for Type-2 diabetics who have not responded to other oral anti-diabetic agents.
Asian Markets Offer Considerable Growth Potential
The Food and Drug Administration (FDA) has detailed stringent policies for the approval of diabetic drugs. These policies compel lengthier clinical trials, often resulting in the delayed launch of new drugs and increased drug development costs. “The not-so conducive regulatory environment, varying price controls across countries and parallel trading hinders the growth of the global diabetes market,” adds the analyst. “In addition, generic competition arising due to patent expiries of major drugs is also restraining market expansion.”
Despite these obstacles, the diabetes market is, and will continue to be, a lucrative segment of the healthcare industry. Numerous innovative drugs and drug-delivery devices are currently being researched. Given these are successful, the launch of such drugs and devices will further open up the market and boost revenue generation. “Asian markets, especially India and China, offer tremendous prospects for growth,” concludes the analyst. “These markets have large diabetic populations and, with the number of undiagnosed diabetics increasing, lucrative untapped opportunities are emerging for pharmaceutical companies.”
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
- Insulin
- Insulin analogues
- Non-insulin anti-diabetic drugs
By Geographic Region:
- The U.S.
- Europe
- Japan
- Rest-of-World
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
The World Diabetes Market, 2007-2025: An analysis of Diabetes Drug and Insulin Market
Market Research of Diabetes and its Treatment Medicine-Insulin in China, 2008
Diabetes
Diabetes, Metabolic Syndrome and Cardiovascular Disease
Chinese Markets for Diabetes Drugs
Stakeholder Insight: Diabetes
Strategic Analysis of the South African Diabetes Markets
Opportunities Assessment for Diabetes Therapeutics - Australia
Diabetes Diagnostics - Global Strategic Business Report
China Anti-Diabetic Drug Market Report 2008
Diabetes Diagnostics - A Global Market Perspective
The Global Diabetes Market: Therapeutics, Diagnostics and Complications
|
|
|
|
